On 16 November 2021, Alzheimer Europe held an online session of its popular Alzheimer's Association Academy (AAA) series. The topic for this session, which was chaired by Dianne Gove, Director for Projects at Alzheimer Europe, was on gender, sex and sexuality in dementia.
On 19 November, the Council of the European Union adopted the Single Basic Act, a regulation aimed at facilitating the launch of 9 new Joint Undertakings under the Horizon Europe Research & Innovation Framework Programme, including the Innovative Health Initiative (IHI).
The European Platform for Neurodegenerative Diseases (EPND) is an Innovative Medicines Initiative project which aims to build a collaborative platform for data and biosample sharing, to accelerate the discovery and validation of biomarkers for neurodegenerative diseases.
The 31st Alzheimer Europe Conference (#31AEC) “Resilience in dementia: Moving beyond the COVID-19 pandemic” was held from 29 November to 1 December 2021. Over 600 participants from 38 countries attended the event, which was Alzheimer Europe’s second virtual conference.
Alzheimer Europe's new website went live on 29 November. We have streamlined the content and made navigation easier and more accessible. The look is clean and modern and the site is adapted to mobile devices as well. The new-look, updated and more user-friendly site can be reached at the same address as before: www.alzheimer-europe.org
This newsletter received funding under an operating grant from the European Union’s Health Programme (2014-2020).
The content of this newsletter represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.